Arvinas Inc (NAS:ARVN)
$ 8.75 +0.065 (+0.75%) Market Cap: 572.13 Mil Enterprise Value: 12.23 Mil PE Ratio: 87.50 PB Ratio: 1.02 GF Score: 69/100

Arvinas Inc at Barclays Global Healthcare Conference Transcript

Mar 10, 2026 / 03:00 PM GMT
Release Date Price: $13.83 (+3.44%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ARVN.OQ - Arvinas Inc
Arvinas Inc at Barclays Global Healthcare Conference
Mar 10, 2026 / 03:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Great. Hello again, everyone. I'm Edsel Drou, a senior biotech analyst at Barclays. It's my pleasure to have Arvius, with us, for our next session. I have Randy Teal, Chief Executive Officer, and Angela Kakkase, Chief Scientific Officer, at AR Venus, thank you guys for joining us today. Randy, maybe just, give us an overview of our Venus, where you are, today, and then we'll, jump into.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Q&A. I will, thank you very much and thank you to Barclays for having us down here. Yes, so our Venus, as we start 2026, has 4 programs in phase
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot